---
title: "RXDX.US (RXDX.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/RXDX.US/news.md"
symbol: "RXDX.US"
name: "RXDX.US"
parent: "https://longbridge.com/zh-HK/quote/RXDX.US.md"
datetime: "2026-03-17T16:25:10.992Z"
locales:
  - [en](https://longbridge.com/en/quote/RXDX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RXDX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RXDX.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/RXDX.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/RXDX.US/news.md)


# RXDX.US (RXDX.US) — 相關新聞

### [Promotica Expands Treasury Share Position Under Ongoing Buyback Program](https://longbridge.com/zh-HK/news/279249299.md)
*2026-03-16T10:55:06.000Z*
> Promotica Expands Treasury Share Position Under Ongoing Buyback Program

### [QuantX Biosciences received Series B funding](https://longbridge.com/zh-HK/news/275453983.md)
*2026-02-10T12:04:16.000Z*
> QuantX Biosciences announced the completion of its Series B financing on February 10, 2026, with investors including San

### [Oncolytic virus therapy sees growth with 100+ companies in clinical trials worldwide, including Candel Therapeutics, Binhui Biopharmaceutical, Oncolytics Biotech, EpicentRx, Hangzhou Converd.](https://longbridge.com/zh-HK/news/274884343.md)
*2026-02-04T23:13:35.000Z*
> In the last ten years, the oncolytic virus therapy sector has seen consistent growth, with more than 100 companies globa

### [Prometheum Secures Additional $23 Million for U.S. Digital Market Expansion](https://longbridge.com/zh-HK/news/274516032.md)
*2026-02-02T12:48:59.000Z*
> Prometheum, a U.S. digital asset market infrastructure provider, has secured an additional $23 million in funding from h

### [TRex Bio, Inc. announced that it has received $50 million in funding from a group of investors](https://longbridge.com/zh-HK/news/273856839.md)
*2026-01-27T14:32:57.000Z*
> TRex Bio, Inc. announced it has secured $50 million in funding on January 27, 2026. The funding round saw participation 

### [ProRx Pharma Redefines Hormone Therapy with Needle-Free Oral Testosterone Option](https://longbridge.com/zh-HK/news/273405155.md)
*2026-01-22T17:09:04.000Z*
> ProRx Pharma has launched a needle-free oral testosterone formulation, aimed at enhancing hormone therapy accessibility.

### [Doseology Sciences Launches Pilot Production of Caffeine-Based Energy Pouches](https://longbridge.com/zh-HK/news/273243963.md)
*2026-01-21T14:18:05.000Z*
### [08:05 ET
			
			
				Redox Bio-Nutrients becomes First Company to have Two Certified Biostimulant Products](https://longbridge.com/zh-HK/news/273088900.md)
*2026-01-20T13:07:04.000Z*
> Redox Bio-Nutrients, LLC has announced that its biostimulant product Mainstay® Si has received certification from The Fe

### [The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings](https://longbridge.com/zh-HK/news/272993565.md)
*2026-01-19T17:24:47.000Z*
> The global consumer healthcare market is projected to reach $362.17 billion by 2026, with regulatory compliance becoming